GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL

被引:0
|
作者
Hess, V. [1 ]
Pestalozzi, B. [2 ]
Ludwig, C. [3 ]
Winterhalder, R. [4 ]
Lohri, A. [5 ]
Jost, L. [6 ]
Widmer, L. [7 ]
Lee, L. [1 ]
Stillhart, P. [1 ]
Herrmann, R. [1 ]
机构
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] St Clara Hosp, Basel, Switzerland
[4] Kantonsspital Luzern, Luzern, Switzerland
[5] Kantonsspital Liestal, CH-4410 Liestal, Switzerland
[6] Kantonsspital Bruderholz, Bruderholz, Switzerland
[7] Onkozentrum Hirslanden, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:181 / 181
页数:1
相关论文
共 50 条
  • [31] A PHASE II TRIAL OF GEMCITABINE IN COMBINATION WITH OXALIPLATIN AND CAPECITABINE IN PREVIOUSLY UNTREATED METASETATIC OR RECURRENT PANCREATIC CANCER
    Sym, S. J.
    Hong, J.
    Jung, M.
    Koo, Y. S.
    Park, Y. H.
    Kim, K. K.
    Park, J.
    Cho, E. K.
    Lee, J. H.
    Shin, D. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 152 - 152
  • [32] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A.
    Martin, W.
    Hartmann, D.
    Eickhoff, J. C.
    Moehler, M.
    Galle, P. R.
    Riemann, J. F.
    Jakobs, R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1572 - 1574
  • [33] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    A Eickhoff
    W Martin
    D Hartmann
    J C Eickhoff
    M Möhler
    P R Galle
    J F Riemann
    R Jakobs
    British Journal of Cancer, 2006, 94 : 1572 - 1574
  • [34] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [35] Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
    Tan, B. R.
    Brenner, W. S.
    Picus, J.
    Marsh, S.
    Gao, F.
    Fournier, C.
    Fracasso, P. M.
    James, J.
    Yen-Revollo, J. L.
    Mcleod, H. L.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1742 - 1748
  • [36] A Phase II Trial of Gemcitabine and Erlotinib (GE) plus Proton Chemotherapy (PCT) and Capecitabine and Oxaliplatin (CapOx) for Locally Advanced Pancreatic Cancer
    Coffman, A. R.
    Hsueh, C. T.
    Hernandez, M.
    Mirshahidi, S.
    Wang, J.
    Solomon, N. L.
    Garberoglio, C. A.
    Reeves, M. E.
    Slater, J. D.
    Yang, G. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E599 - E600
  • [37] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Kim, Se Hyun
    Shin, Sang Joon
    Kim, Sun Young
    Lee, Se Hoon
    Park, Young Suk
    Park, Se Hoon
    Lee, Kyung Hee
    Kim, Tae Won
    Hong, Yong Sang
    Ahn, Joong Bae
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 91 - 97
  • [38] Combining Capecitabine, Oxaliplatin and Gemcitabine (XELOXGEM) for Colorectal Carcinoma Patients Pretreated With Irinotecan - a Multicenter Phase I/II Trial
    Kim, S. H.
    Shin, S. J.
    Kim, S. Y.
    Lee, S. H.
    Park, Y. S.
    Lee, K. H.
    Kim, T. W.
    Hong, Y. S.
    Ahn, J. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S425 - S425
  • [39] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Se Hyun Kim
    Sang Joon Shin
    Sun Young Kim
    Se Hoon Lee
    Young Suk Park
    Se Hoon Park
    Kyung Hee Lee
    Tae Won Kim
    Yong Sang Hong
    Joong Bae Ahn
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 91 - 97
  • [40] Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial
    Knox, JJ
    Hedley, D
    Oza, A
    Feld, R
    Sin, LL
    Chen, E
    Nematollahi, M
    Pond, GR
    Zhang, J
    Moore, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2332 - 2338